US HB5377 | 2021-2022 | 117th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 14-6)
Status: Introduced on September 27 2021 - 25% progression, died in committee
Action: 2021-09-27 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 27 2021 - 25% progression, died in committee
Action: 2021-09-27 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To facilitate the development of treatments for cancers, and for other purposes.
Title
Cancer Patient Equity Act of 2021
Sponsors
Rep. G. Butterfield [D-NC] | Rep. Gus Bilirakis [R-FL] | Rep. Garland Barr [R-KY] | Rep. Brian Fitzpatrick [R-PA] |
Rep. Don Bacon [R-NE] | Rep. Charles Fleischmann [R-TN] | Rep. Dina Titus [D-NV] | Rep. Michael Doyle [D-PA] |
Rep. Raul Grijalva [D-AZ] | Rep. Kevin Hern [R-OK] | Rep. Lori Trahan [D-MA] | Rep. Jake Auchincloss [D-MA] |
Rep. Conor Lamb [D-PA] | Rep. Mark DeSaulnier [D-CA] | Rep. Joseph Neguse [D-CO] | Rep. Marc Veasey [D-TX] |
Rep. Michael San Nicolas [D-GU] | Rep. Pete Aguilar [D-CA] | Rep. Susan Wild [D-PA] | Rep. Debbie Wasserman Schultz [D-FL] |
History
Date | Chamber | Action |
---|---|---|
2021-09-27 | House | Referred to the Subcommittee on Health. |
2021-09-27 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2021-09-27 | House | Introduced in House |
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/117th-congress/house-bill/5377/all-info |
Text | https://www.congress.gov/117/bills/hr5377/BILLS-117hr5377ih.pdf |